ClinicalTrials.gov
ClinicalTrials.gov Menu

Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02650128
Recruitment Status : Active, not recruiting
First Posted : January 8, 2016
Last Update Posted : February 7, 2017
Sponsor:
Information provided by (Responsible Party):
Shockwave Medical, Inc.

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : September 2016
  Estimated Study Completion Date : March 2017

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 March 7, 2017
(Canceled - Date Unknown)
April 4, 2017
June 16, 2017
2 August 10, 2017
February 16, 2018
3 March 14, 2018